Neurochem Int 61:11211132 Lamhonwah AM, Hawkins CE, Tam C, Wong J, Mai L, Tein I (2008) Expression patterns of the organic cation/carnitine transporter family in adult murine brain
These medications, commonly administered via injections, are referred to as GLP-1 receptor agonists
adults without diabetes more than tripled between 2018 and 2022, with annual spending surging from $1.6 billion to $5.8 billion.
How GLP-1 works: GLP-1 is a hormone produced in the gut during digestion that may help to maintain a feeling of fullness and support metabolic health
If you have established atherosclerotic cardiovascular disease, your healthcare provider will likely recommend one of these agents with proven cardiovascular benefit
1- Why 2026 could be the year where GLP-1 becomes mainstream